CEL-SCI Corporation (AMEX:CVM) has a beta of 2.29. The stock’s Relative Strength Index (RSI) is 46.95, with weekly volatility at 9.09% and ATR at 2.08. The CVM stock’s 52-week price range has touched low of $10.76 and a $40.91 high. Its shares traded lower over the last trading session, losing -6.36% on 05/06/21. The shares fell to a low of $19.39 before closing at $19.86. Intraday shares traded counted 0.89 million, which was 9.38% higher than its 30-day average trading volume of 986.48K. CVM’s previous close was $21.21 while the outstanding shares total 40.53M.
Investors have identified the Biotechnology company CEL-SCI Corporation as an interesting stock but before investments are made there, an in-depth look at its trading activities will have to be conducted. The share is trading with a market value of around $839.68 million, the company now has both obstacles and catalysts that affect them and they came from their mode of operations. With the company affected by events currently, it is a perfect time to analyze the numbers behind the firm in order to come up with a rather realistic picture of what this stock is.
CEL-SCI Corporation (CVM) Fundamentals that are to be considered.
When analyzing a stock, the first fundamental thing to take into account is the balance sheet. How healthy the balance sheet of a company is will determine if the company will be able to carry out all its financial and non-financial obligations and also keep the faith of its investors. For CVM, the company has in raw cash 21.86 million on their books with 0.62 million currently as liabilities. How the trend is over time is what investors should be concerned about. The company has a healthy balance sheet as their debt profile has been on an incline. In terms of their assets, the company currently has 23.7 million total, with 7.33 million as their total liabilities.
Having a look at the company’s valuation, the company is expected to record 1.05 total earnings per share during the next fiscal year. It is very important though to remember that the importance of trend far outweighs that of outlook. This analysis has been great and getting further updates on CVM sounds very interesting.
Is the stock of CVM attractive?
In related news, Senior Vice President, CIPRIANO JOHN sold 10,000 shares of the company’s stock in a transaction that recorded on Apr 22. The sale was performed at an average price of 24.38, for a total value of 243,793. As the sale deal closes, the Director, YOUNG PETER R now bought 100 shares of the company’s stock, valued at 1,424. Also, Director, BAILLAVOINE BRUNO JEAN-MARIE bought 800 shares of the company’s stock in a deal that was recorded on Nov 18. The shares were price at an average price of 11.77 per share, with a total market value of 9,416. Following this completion of acquisition, the Director, Watson Robert Eugene now holds 800 shares of the company’s stock, valued at 9,416. In the last 6 months, insiders have changed their ownership in shares of company stock by 4.10%.
1 out of 1 analysts covering the stock have rated it a Buy, while 0 have maintained a Hold recommendation on CEL-SCI Corporation. 0 analysts has assigned a Sell rating on the CVM stock. The 12-month mean consensus price target for the company’s shares has been set at $19.00.